Combinations comprising pregabalin
AssigneePfizer Inc.
InventorKevin Paul Gunn
Life of this patent
Estimating the term…
Abstract
The invention relates to a combination of pregabalin and 1-(2-ethoxyethyl)-5-[ethyl(methyl)amino]-N-mesyl-7-[(4-methyl-2-pyridyl)amino]-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide, to pharmaceutical compositions containing the combination, and to the use of the combination in the treatment of pain.
Claims9
A combination comprising pregabalin, or a pharmaceutically acceptable salt thereof, and 1-(2-ethoxyethyl)-5-[ethyl(methyl)amino]-N-mesyl-7-[(4-methyl-2-pyridyl)amino]-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide, or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising pregabalin, or a pharmaceutically acceptable salt thereof;
- 1-(2-ethoxyethyl)-5-[ethyl(methyl)amino]-N-mesyl-7-[(4-methyl-2-pyridyl)amino]-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide, or a pharmaceutically acceptable salt thereof;
- and one or more pharmaceutically acceptable excipients.
A method for the treatment of pain comprising administering a therapeutically effective amount of pregabalin, or a pharmaceutically acceptable salt thereof, and 1-(2-ethoxyethyl)-5-[ethyl(methyl)amino]-N-mesyl-7-[(4-methyl-2-pyridyl)amino]-1H-pyrazolo[4,3-d]pyrimidine-3-carboxamide, or a pharmaceutically acceptable salt thereof, to a mammal in need of said treatment.
Dependencies are inferred from the claim text.